Invention Grant
- Patent Title: Farnesoid X receptor modulators
-
Application No.: US14120366Application Date: 2014-05-14
-
Publication No.: US09611289B2Publication Date: 2017-04-04
- Inventor: Roberto Pellicciari
- Applicant: Intercept Pharmaceuticals, Inc.
- Applicant Address: US NY New York
- Assignee: Intercept Pharmaceuticals, Inc.
- Current Assignee: Intercept Pharmaceuticals, Inc.
- Current Assignee Address: US NY New York
- Agency: Cooley LLP
- Agent Ivor R. Elrifi; Heidi A. Erlacher
- Main IPC: A61K31/56
- IPC: A61K31/56 ; C07J9/00 ; C07J41/00 ; C07J31/00 ; C07J71/00
Abstract:
The present invention provides a compound of formula (I): or a pharmaceutically acceptable salt, solvate, or amino acid conjugate thereof, wherein R1, R2, R3, R4, R5, and R6 are as described herein. The present invention relates generally to selective FXR agonists and to methods of making and using them.
Public/Granted literature
- US20140371190A1 Farnesoid X receptor modulators Public/Granted day:2014-12-18
Information query
